FDA Panel Says Yes to Pfizer Booster Shots for People 65+
Same independent panel of experts said no to booster shots for Americans younger than 65 years
Allergic Reactions to mRNA COVID-19 Vaccines Characterized
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria
Delta Variant Now Fueling 99 Percent of U.S. COVID-19 Cases
The delta variant is driving the increase in hospitalizations
Review of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: Fauci
Fauci says data on booster shots for those vaccines are only a few weeks away from a review by the FDA
Physician’s Briefing Weekly Coronavirus Roundup
Parents Increasingly Cite Safety Concerns in HPV Vaccine Refusal
Despite 79.9 percent increase in parent-reported safety concerns, there was a drop in HPV vaccine-related reported adverse reactions
FDA Advisory Panel to Hold Meeting Today on COVID-19 Booster Shots
Advisory panel will review a variety of evidence, including new data from Israel
Most Highly Allergic People Can Be Safely Immunized Against COVID-19
Algorithm enables immunization of most individuals, with 0.7 percent developing anaphylactic reaction after one BNT162b2 dose
Individuals With COVID-19 Most Infectious Around Symptom Onset
Individuals are most infectious in the two days before and three days after symptom onset
Risk for Asthma at Age 4 Years Higher After Pneumonia in Infancy
Risk slightly higher after introduction of nationwide pneumococcal conjugate vaccine
